Ha Kung Wong practices general intellectual property law with an emphasis on complex patent and trade secret litigation in pharmaceuticals, biologics and chemistry. Cases Ha Kung has litigated include those related to proton pump inhibitors, anti-epileptic drugs, anti-tussives and other pharmaceuticals. Mr. Wong also has extensive experience with inter partes review (IPR), intellectual property counseling, pre-suit investigations, licensing and due diligence.
Mr. Wong is the recipient of the 2017 ILO Client Choice Individual Award for Intellectual Property in New York. He is currently the Chair of the Recruiting Committee, serves as faculty for NITA (the National Institute of Trial Advocacy) and Lawline, and has been named a "Furthered 40" by Lawline for his contributions. He is also an Advisory Board Member for The Center for Biosimilars.
Ha Kung was named to The National Law Journal's 2017 inaugural list of Elite Boutique Trailblazers.